|
|
|
|
| LEADER |
00000pam a22000004a 4500 |
| 001 |
4748323 |
| 003 |
ICU |
| 005 |
20031021183900.0 |
| 008 |
020327s2002 enka b 101 0 eng |
| 010 |
|
|
|a 2002021795
|
| 020 |
|
|
|a 1852335637 (alk. paper)
|
| 035 |
|
|
|a 2002021795
|
| 035 |
|
|
|a (DNLM)101141749
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d DLC
|d OCoLC
|d OrLoB-B
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a RC280.G4
|b G48 2001
|
| 060 |
1 |
0 |
|a QZ 310
|b G372g 2002
|
| 082 |
0 |
0 |
|a 616.99/263
|2 21
|
| 111 |
2 |
|
|a Germ Cell Tumour Conference
|n (5th :
|d 2001 :
|c University of Leeds)
|
| 245 |
1 |
0 |
|a Germ cell tumours V :
|b the proceedings of the Fifth Germ Cell Tumour Conference : Devonshire Hall, University of Leeds, 13th-15th September, 2001 /
|c P. Harnden, J.K. Joffe, and W.G. Jones (eds).
|
| 246 |
3 |
|
|a Germ cell tumours five
|
| 246 |
3 |
|
|a Germ cell tumours 5
|
| 260 |
|
|
|a London ;
|a New York :
|b Springer,
|c c2002.
|
| 300 |
|
|
|a xvi, 284 p. :
|b ill. ;
|c 24 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|g 1.
|t The Genetics of Testicular Germ Cell Tumours /
|r E. A. Rapley, G. P. Crockford and D. F. Easton /
|r [et al.] --
|g 2.
|t Advances in the Understanding of Germ Cell Tumour Biology /
|r J. Houldsworth, V. V. V. S. Murty and G. J. Bosl /
|r [et al.] --
|g 3.
|t A Notch-related Gene Located on the Long Arm of Human Chromosome 12 /
|r D. Adamah, P. J. Gokhale and J. Walsh /
|r [et al.] --
|g 4.
|t Investigating Gain of 12p Material in Testicular Germ Cell Tumours and Its Apparent Absence in Carcinoma in situ /
|r B. Summersgill, O. Jafer and H. Goker /
|r [et al.] --
|g 5.
|t Overrepresentation of the Short Arm of Chromosome 12 Is Related to Invasive Growth of Testicular Seminomas and Non-seminomas /
|r J. W. Oosterhuis, R. J. H. L. M. van Gurp and C. Rosenberg /
|r [et al.] --
|g 6.
|t Reactivity of Germ Cell Maturation Stage-specific Markers in Classical and Spermatocytic Seminoma /
|r L. H. J. Looijenga, H. Stoop and R. J. H. L. M. van Gurp /
|r [et al.] --
|g 7.
|t Expression of Human endogenous Retroviruses HERV-K/HTDV in Germ Cell Tumours: Possible Biological Role and Clinical Application /
|r A. Kleiman, N. Senyuta and A. Trijakin /
|r [et al.] --
|g 8.
|t No Association Between HLA Class II Genes and Testicular Germ Tumour (TGCT) with Genotyping of the HLA-Region on Chromosome 6p21 and Haplotype Sharing Analysis /
|r M. F. L. Holzik, D. J. A. Sonneveld and H. J. Hoekstra /
|r [et al.] --
|g 9.
|t RT-PCR for AFP, HCG, GCAP and PDGF-1 To Detect Circulating Tumour Cells in Testicular Germ Cell Tumours /
|r A. Heidenreich --
|g 10.
|t The Prognostic Significance of Tumour Infiltrating Lymphocyte Count in Stage I Testicular Seminoma Managed by Surveillance /
|r C. Parker, M. Milosevic and P. Warde /
|r [et al.] --
|g 11.
|t HIV Related Testicular Cancer /
|r T. Powles, M. Bower and M. Nelson /
|r [et al.] --
|g 12.
|t Microinvasive Testicular Germ Cell Tumours: Prevalence in Stage I Tumours /
|r F. E. von Eyben and G. K. Jacobsen --
|g 13.
|t Serum Lactate Dehydrogenase Isoenzyme 1 in Patients with Testicular Seminoma or Nonseminoms Stage I: Two Nationwide Danish Studies of Surveillance /
|r F. E. von Eyben, G. K. Jacobsen and L. Specht /
|r [et al.] --
|g 14.
|t The Atrophy Hypothesis and Development of Malignant Germ Cell Cancers of the Testis /
|r R. T. D. Oliver --
|g 15.
|t Prognosis and Prognostic Factors /
|r M. K. Gospodarowicz and B. O'Sullivan --
|g 16.
|t Role of the Human Apurinic Endonuclease Apel/Ref-1 in Germ Cell Tumours /
|r M. R. Kelley, D. Wang and S.-H. Jung /
|r [et al.] --
|g 17.
|t Translational Implications of Apel in Germ Cell Tumours: Apel as a Therapeutic Target /
|r M. R. Kelley, M. Luo and Y. Xu /
|r [et al.] --
|g 18.
|t Current Clinical Trials in Germ Cell Tumours in the United States /
|r C. R. Nichols --
|g 19.
|t Topoisomerase I and II in Germ Cell Cancer as Indicators of Possible Drug Selection for Salvage Chemotherapy Studies /
|r D. M. Berney, J. Shamash and J. Gaffney /
|r [et al.] --
|g 20.
|t Overview of Female Germ Cell Tumours /
|r S. A. Tjulandin --
|g 21.
|t Germ Cell Tumours of the Ovary: a Clinicopathological Study of 121 Cases from Nepal /
|r S. P. Sah, D. Upreti and M. Lakhey /
|r [et al.] --
|g 22.
|t Serum Lactate Dehydrogenase Isoenzyme 1 in Patients with Testicular and Ovarian Germ Cell Tumours /
|r F. E. von Eyben, M. R. Mirza and E. L. Madsen /
|r [et al.] --
|g 23.
|t Low Dose Bleomycin Every Three Weeks with Cisplatin and Etoposide Results in Excellent Event Free and Survival Rates for Children and Adolescents with Gonadal Malignant Germ Cell Tumours (MGCT): A POG/CCG Intergroup Report /
|r J. W. Cullen, T. A. Olson and R. H. Giller /
|r [et al.] --
|g 24.
|t Treatment Strategy for Childhood Extracranial Secreting Germ Cell Tumours Based on Alphafoetoprotein (AFP) Level: Protocol TGM95 of the Societe Francaise d'Oncologie Pediatrique (SFOP) /
|r C. Patte, E. Quintana and D. Frappaz /
|r [et al.] --
|g 25.
|t Risk Factors in Malignant Extracranial Germ Cell Tumours (MGCTs) of Childhood: Analysis of UKCCSG's GCII Study /
|r J. R. Mann, F. Raafat and K. Robinson /
|r [et al.] --
|g 26.
|t A Watch-and-Wait-Strategy Is a Safe Procedure in Children and Adolescents with Malignant Non-testicular Germ Cell Tumours (GCTs): Results of the German Consecutive MAKEI 83/86/89 and 96 Protocols /
|r U. Gobel, G. Calaminus and J. Engert /
|r [et al.] --
|g 27.
|t Mediastinal Germ Cell Tumours (MGCT) in Children and Adolescents: Age Correlates with Histological Differentiation, Genetic Profiles and Clinical Outcome /
|r D. T. Schneider, E. J. Perlman and D. Harms /
|r [et al.] --
|g 28.
|t Intracranial Malignant Germ Cell Tumours (CNS GCTs): Interim Results of the SIOP Trial /
|r G. Calaminus, M. L. Garre and J. R. Mann /
|r [et al.] --
|g 29.
|t Treatment of Primary Intracranial Germ Cell Tumours with Carboplatin-based Chemotherapy and Focal Irradiation /
|r C. Patte, D. Frappaz and M. A. Raquin /
|r [et al.] --
|g 30.
|t Patterns of Relapse Following Focal Irradiation of Intracranial Germinoma: Critical Review of TGM-TC90 SFOP Protocol /
|r C. Alapetite, C. Carrie and H. Brisse /
|r [et al.] --
|g 31.
|t Impact of Residual Lesions in Intracranial Germinoma- Interim Results from the SIOP CNS GCT 96 Study /
|r S. Eisert, J. Nicholson and F. Saran /
|r [et al.] --
|g 32.
|t Failure of Treatment in Childhood Extracranial and Extratesticular Malignant Germ Cell Tumours (MGCT) /
|r M. Lo Curto, P. D'Angelo and G. Turdo /
|r [et al.] --
|g 33.
|t Surgery for Germ Cell Tumours: Current Status in the USA /
|r R. S. Foster, R. Bihrle and J. P. Donohue --
|g 34.
|t Surgery for Testicular Cancer: UK and European Experience /
|r D. Kirk --
|g 35.
|t Resection of Residual Masses: a Decade of Research with Jan Keizer /
|r E. W. Steyerberg --
|g 36.
|t Predictive Factors for Residual Teratoma after Chemotherapy for Non- seminomatous Germ Cell Tumours (NSGCT) /
|r L. H. Larsen and H. von der Maase --
|g 37.
|t Orchidectomy Following Chemotherapy for Patients with Metastatic Testicular Germ Cell Cancer /
|r T. Geldart --
|g 38.
|t Organ Sparing Tumour Resection in Testicular Germ Cell Tumours (TGCT) - Long-term Follow-up /
|r A. Heidenreich --
|g 39.
|t Chemotherapy for Testis Conservation in Patients with Germ Cell Cancer (GCC): Is It Safe and Could Combination with Tumour Enucleation Increase the Frequency of Success? /
|r V. Nargund, T. Lane and R. T. D. Oliver /
|r [et al.] --
|g 40.
|t How Valid Is a Prediction Rule for Residual Retroperitoneal Mass Histology in NSGCT? /
|r Y. Vergouwe, E. W. Steyerberg and J. D. F. Habbema --
|g 41.
|t Minimizing Morbidity from Surgery for Non-seminoma Testicular Cancer /
|r M. A. S. Jewett, B. Shekarriz and A. Grabowski --
|g 42.
|t Quality of Life in Patients with Good Prognosis Metastatic Germ Cell Tumours: Comparison of Four Chemotherapy Schedules (EORTC 30941 / MRC TE20) /
|r S. D. Fossa, L. Collette and N. Aaronson /
|r [et al.] --
|g 43.
|t Introducing the Measurement of Quality of Life into Clinical Practice: Technology and Mechanisms /
|r R. Sanders, G. Velikova and A. Smith /
|r [et al.] --
|g 44.
|t Mortality Rates in Patients with Malignant Germ Cell Tumours (MGCT) with Emphasis on Second Cancer and Cardiovascular Mortality /
|r N. Aass, S. D. Fossa and S. Harvei /
|r [et al.] --
|g 45.
|t Cardiovascular Disease as a Long Term Complication of Treatment for Testicular Cancer /
|r R. A. Huddart, A. Norman and M. Shahidi /
|r [et al.] --
|g 46.
|t Fertility and Quality of Life after Treatment for Testicular Cancer /
|r R. A. Huddart, A. Norman and C. Moynihan /
|r [et al.] --
|g 47.
|t The Prevalence of Avascular Necrosis in Patients Treated with Chemotherapy for Testicular Tumours /
|r A. M. Cook, A. S. K. Dzik-Jurasz and A. R. Padhani /
|r [et al.] --
|g 48.
|t Factors Assocated with Bleomycin Lung Toxicity in Germ Cell Tumour Patients Treated at the Royal Marsden Hospital Between 1982 and 1999 /
|r J. M. O'Sullivan, A. R. Norman and J. Nicholls /
|r [et al.] --
|g 49.
|t The Provision of an Adolescent Service to Patients Aged up to 25 Years Attending the Germ Cell Tumour Service, Leeds /
|r S. Morgan --
|g 50.
|t Chemotherapy for Germ Cell Tumours in the United States /
|r C. R. Nichols --
|g 51.
|t The Current Status of Radiotherapy in the Management of Germ Cell Tumours /
|r M. Mason --
|g 52.
|t Limited Volume Short Course Radiation for Stage I Seminoma of the Testis /
|r J. P. Logue and J. E. Livsey --
|
| 505 |
8 |
0 |
|g 53.
|t A Randomised Trial of Two Radiotherapy Schedules in the Adjuvant Treatment of Stage I Seminoma (MRC TE18) - Preliminary Report /
|r W. G. Jones, S. D. Fossa and G. M. Mead /
|r [et al.] --
|g 54.
|t Metastatic Seminoma: Should Treatment Be Different from Non-seminoma? /
|r J. Ong, R. T. D. Oliver and J. Shamash /
|r [et al.] --
|g 55.
|t GAMEC - a Novel Protocol for IGCCCG Poor Prognosis and Relapsing Germ Cell Tumours /
|r J. Shamash, R. T. D. Oliver and J. P. C. Steele /
|r [et al.] --
|g 56.
|t Adjuvant Chemotherapy in High-risk Stage I Non-seminomatous Germ Cell Tumours: the Spanish Germ Cell Cancer Group Experience /
|r P. Maroto, X. Garcia del Muro and M. Lomas /
|r [et al.] --
|g 57.
|t Single Agent Carboplatin for Advanced Seminoma: Effective Initial Therapy /
|r N. L. Fernie and V. J. Harvey --
|g 58.
|t Bleomycin in Combination Chemotherapy of Testicular or Extragonadal Germ Cell Tumours: a Review of Published Trials /
|r L. Boublikova, R. T. D. Oliver and J. Shamash /
|r [et al.] --
|g 59.
|t Long Term Follow Up of Anglian Germ Cell Cancer Group Studies of Chemotherapy for Stage I Non Seminoma /
|r R. T. D. Oliver, J. Ong and R. Ravi /
|r [et al.] --
|g 60.
|t Radiation Risk in the Follow-up of Early Stage Germ Cell Tumours and Newer Imaging Modalities /
|r S. Swift --
|g 61.
|t FDG PET Scanning in Germ Cell Tumours /
|r R. A. Huddart and S. F. Hain --
|g 62.
|t Vascular Anomalies in Patients Undergoing Retroperitoneal Lymph Node Dissection (RPLND) for Testicular Germ Cell Tumours (TGCT) /
|r A. Heidenreich and A. Elert --
|g 63.
|t The 5 Year Experience of a Rapid Access Diagnostic Testicular Swelling Clinic /
|r C. J. Luscombe, A. P. Doherty and A. Elves /
|r [et al.] --
|g 64.
|t Negative Predictive Value of "Clean Retroperitoneum" by Ultrasound in Patients with Testicular Cancer /
|r Z. Mezvrishvili, T. Toidze and N. Turmanidze /
|r [et al.] --
|g 65.
|t Multivariate Analysis of Predictive Factors of Late Relapse in 1264 Patients with Testicular Germ Cell Tumours /
|r M. Shahidi, A. R. Norman and J. Nicholls /
|r [et al.] --
|g 66.
|t Risks and Benefits of Follow-up of Early Germ Cell Tumours - a Survey of Current Practice /
|r J. K. Joffe --
|g 67.
|t Survey of the Management of Brain Metastases from Malignant Germ Cell Tumours on Clinical Presentation /
|r H. Charalambous, I. D. Pedley and J. T. Roberts.
|
| 650 |
|
0 |
|a Germ cells
|x Tumors
|v Congresses.
|
| 650 |
|
0 |
|a Testis
|x Tumors
|v Congresses.
|
| 650 |
1 |
2 |
|a Germinoma
|x therapy
|v Congresses.
|
| 650 |
2 |
2 |
|a Germinoma
|x surgery
|v Congresses.
|
| 650 |
2 |
2 |
|a Ovarian Neoplasms
|v congresses.
|
| 650 |
2 |
2 |
|a Testicular Neoplasms
|v Congresses.
|
| 650 |
|
7 |
|a Testis
|x Tumors.
|2 fast
|0 http://id.worldcat.org/fast/fst01148283
|
| 655 |
|
7 |
|a Conference papers and proceedings.
|2 fast
|0 http://id.worldcat.org/fast/fst01423772
|
| 700 |
1 |
|
|a Harnden, P.
|0 http://id.loc.gov/authorities/names/n94082986
|1 http://viaf.org/viaf/92207324
|
| 700 |
1 |
|
|a Joffe, J. K.
|q (Jonathan K.),
|d 1958-
|0 http://id.loc.gov/authorities/names/n2002133868
|1 http://viaf.org/viaf/58446573
|
| 700 |
1 |
|
|a Jones, W. G.
|0 http://id.loc.gov/authorities/names/n85001958
|1 http://viaf.org/viaf/94555780
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 035 |
|
|
|a (OCoLC)48783370
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i 16f6edcd-b111-5652-86ae-861432e467db
|s 18589645-453a-5729-a58a-470f40c6a0f4
|
| 928 |
|
|
|t Library of Congress classification
|a RC280.G4 G48 2001
|l ASR
|c ASR-SciASR
|i 4330164
|
| 927 |
|
|
|t Library of Congress classification
|a RC280.G4 G48 2001
|l ASR
|c ASR-SciASR
|e MARO
|e CRERAR
|b 63122743
|i 7352102
|
